Johnson & Johnson Target Price

See Johnson & Johnson's analyst price targets ($280) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$265.58

Average Target Price

$283.70

6.8% upside

20 analysts in the last 4 months

High: $320 | Low: $260

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-10	HSBC	$320	20.5% upside
2026-09-02	UBS	$320	20.5% upside
2026-08-06	Guggenheim	$287	8.1% upside
2026-08-03	Wells Fargo	$282	6.2% upside
2026-08-03	Raymond James	$280	5.4% upside
2026-07-29	Argus ResearchDavid Toung	$300	13% upside
2026-07-16	Johnson RiceIlya Zubkov	$280	5.4% upside
2026-07-16	Wells Fargo	$272	2.4% upside
2026-07-16	Morgan StanleyTerence Flynn	$294	10.7% upside
2026-07-16	Johnson Rice	$261	1.7% downside
2026-07-16	Goldman Sachs	$282	6.2% upside
2026-07-16	Scotiabank	$305	14.8% upside
2026-07-16	Raymond James	$265	0.2% downside
2026-07-15	Stifel NicolausRick Wise	$260	2.1% downside
2026-07-13	RBC Capital	$287	8.1% upside
2026-07-08	Morgan StanleyTerence Flynn	$284	6.9% upside
2026-07-06	HSBC	$290	9.2% upside
2026-06-26	GuggenheimVamil Divan	$270	1.7% upside
2026-06-26	Johnson Rice	$270	1.7% upside
2026-05-13	Leerink PartnersDavid Risinger	$265	0.2% downside
2026-04-20	Guggenheim	$266	0.2% upside
2026-04-15	Stifel NicolausRick Wise	$250	5.9% downside
2026-04-15	Morgan Stanley	$283	6.6% upside
2026-04-15	BarclaysMatt Miksic	$255	4% downside
2026-04-15	RBC Capital	$265	0.2% downside
2026-04-10	Morgan Stanley	$267	0.5% upside
2026-03-18	Morgan Stanley	$253	4.7% downside
2026-02-03	RBC Capital	$255	4% downside
2026-01-28	Morgan StanleyTerrance Flynn	$262	1.3% downside
2026-01-27	Loop Capital MarketsIlya Zubkov	$220	17.2% downside
2026-01-23	GuggenheimVamil Divan	$240	9.6% downside
2026-01-22	Morgan StanleyTerence Flynn	$200	24.7% downside
2026-01-22	Wells Fargo	$240	9.6% downside
2026-01-22	Scotiabank	$265	0.2% downside
2026-01-22	Goldman SachsAsad Haider	$250	5.9% downside
2026-01-22	Stifel NicolausRick Wise	$220	17.2% downside
2026-01-09	BernsteinLee Hambright	$208	21.7% downside
2025-12-30	BarclaysMatt Miksic	$217	18.3% downside
2025-12-18	Goldman SachsAsad Haider	$240	9.6% downside
2025-12-17	RBC Capital	$240	9.6% downside
2025-12-12	Morgan Stanley	$197	25.8% downside
2025-12-11	RBC Capital	$230	13.4% downside
2025-12-10	HSBC	$240	9.6% downside
2025-12-05	Guggenheim	$227	14.5% downside
2025-12-02	Barclays	$197	25.8% downside
2025-10-22	Johnson RiceIlya Zubkov	$190	28.5% downside
2025-10-22	Loop Capital MarketsIlya Zubkov	$190	28.5% downside
2025-10-15	Morgan StanleyTerence Flynn	$190	28.5% downside
2025-10-15	Raymond James	$209	21.3% downside
2025-10-15	Argus ResearchDavid Toung	$210	20.9% downside

Johnson & Johnson (JNJ) FAQ

As of the most recent data, JNJ shows a target price of $280. Scroll down for historical charts and peer comparison views.

If Johnson & Johnson moved to the average analyst target of $280, shares would be roughly 6.8% higher than $265.58. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Johnson & Johnson's earnings trajectory.

Besides this target price page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $280) with ownership activity and broader fundamentals.

Johnson & Johnson's target price is $280; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.